Filana Therapeutics, Inc. Increase (Decrease) in Other Accrued Liabilities
Filana Therapeutics, Inc. (FLNA) reported Increase (Decrease) in Other Accrued Liabilities of -$3.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2015-07-23
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-09-30 was $0.00.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-06-30 was -$10.00K.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-03-31 was $7.00K.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for fiscal 2014 was -$3.00K.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for fiscal 2013 was -$21.00K.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for fiscal 2012 was -$58.00K.
- Filana Therapeutics, Inc. increase (decrease) in other accrued liabilities for fiscal 2011 was -$15.00K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $0.00 derived: sum of 2 quarters · filed 2015-02-18 | -$10.00K derived: sum of 3 quarters · filed 2015-07-23 | -$3.00K 10-K · filed 2015-02-18 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$10.00K derived: sum of 2 quarters · filed 2015-07-23 | -$3.00K 10-Q · filed 2014-11-05 | $0.00 derived: sum of 4 quarters · filed 2015-07-23 |
| 2014-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | -$3.00K 10-Q · filed 2015-07-23 | $0.00 derived: sum of 3 quarters · filed 2015-07-23 | $0.00 derived: sum of 4 quarters · filed 2015-07-23 |
| 2014-03-31 | $7.00K 10-Q · filed 2015-05-08 | $10.00K derived: sum of 2 quarters · filed 2015-05-08 | $10.00K derived: sum of 3 quarters · filed 2015-05-08 | $10.00K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $3.00K derived: sum of 2 quarters · filed 2015-02-18 | $3.00K derived: sum of 3 quarters · filed 2015-02-18 | -$21.00K 10-K · filed 2015-02-18 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | -$24.00K 10-Q · filed 2014-11-05 | -$24.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$24.00K 10-Q · filed 2014-08-06 | -$24.00K derived: sum of 3 quarters · filed 2015-02-18 | -$41.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | -$24.00K 10-Q · filed 2014-05-07 | -$24.00K derived: sum of 2 quarters · filed 2015-02-18 | -$41.00K derived: sum of 3 quarters · filed 2015-02-18 | -$34.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | -$17.00K derived: sum of 2 quarters · filed 2015-02-18 | -$10.00K derived: sum of 3 quarters · filed 2015-02-18 | -$58.00K 10-K · filed 2015-02-18 |
| 2012-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$10.00K derived: sum of 2 quarters · filed 2013-11-01 | -$58.00K 10-Q · filed 2013-11-01 | -$72.00K derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$41.00K 10-Q · filed 2013-08-01 | -$55.00K derived: sum of 3 quarters · filed 2014-02-05 | -$69.00K derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-03-31 | -$48.00K 10-Q · filed 2013-04-24 | -$62.00K derived: sum of 2 quarters · filed 2014-02-05 | -$76.00K derived: sum of 3 quarters · filed 2014-02-05 | -$60.00K derived: sum of 4 quarters · filed 2014-02-05 |
| 2011-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-05 | -$28.00K derived: sum of 2 quarters · filed 2014-02-05 | -$12.00K derived: sum of 3 quarters · filed 2014-02-05 | -$15.00K 10-K · filed 2014-02-05 |
| 2011-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.00K derived: sum of 2 quarters · filed 2012-11-09 | -$1.00K 10-Q · filed 2012-11-09 | -$6.00K derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $13.00K 10-Q · filed 2012-08-02 | $8.00K derived: sum of 3 quarters · filed 2013-02-08 | -$16.00K derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-03-31 | -$3.00K 10-Q · filed 2012-05-08 | -$8.00K derived: sum of 2 quarters · filed 2013-02-08 | -$32.00K derived: sum of 3 quarters · filed 2013-02-08 | |
| 2010-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | -$29.00K derived: sum of 2 quarters · filed 2013-02-08 | -$390.00K 10-K · filed 2013-02-08 | |
| 2010-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$385.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$361.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$344.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |